About 2iM
Historic
2iM® was created, in 2011, from a spin-off of Impacto Tecnologia Geracionais em Saúde (Impacto Generational Health Technology). As soon as it was created, it went through a selection process at the Technological Incubator (INTEC) of the Paraná Institute of Technology and was approved without restriction. At the end of 2015 he graduated from the incubator and in 2017 it became a scale-up receiving an investment from the PRIMATEC Fund.
2iM’s value proposition is to use analytics tools to measure Health Value. For this value proposition, 2iM develops applications and systems for health data generation, uses interoperability techniques and solutions, generates specific metrics of quality and cost in health and implements new Value-based payment models.
In 2014 the company enshrined its assistance performance evaluation model, GPS.2iM©, initiating projects in large hospitals; today it is already in use in nearly 30% of ANAHP hospitals, with more than 40,000 doctors evaluated with this tool, in addition to being used by several public and private payers.
2iM is a reference in the market for evaluating the performance of doctors and healthcare services and for implementing Value-based payment models.
Business Definition
Using the Business Analytics (BA) concept, we group, analyze and track health information with a focus on strategic decision making in relation to your institution’s quality and health performance indicators. This concept is about the evolution of BI enabling access, tracking, storage, transformation, modeling, analysis and delivery of information with the main objective of enabling the strategic decision making of its management team and restructuring Value-based remuneration models.
- Mission
- Vision
- Values
Aggregate and generate information to measure Health Value, supporting the system so that it becomes sustainable and improves the quality of people's lives.
In 5 years to be a national reference to measure Health Value, maintaining impartiality and promoting the sustainability of the sector.
Integrity Social responsability Exemption Commitment to results Innovation
Team

DR. CÉSAR ABICALAFFE
Chairman e CEO
Dr. César Luiz Lacerda Abicalaffe is a doctor graduated in 1986, with a Master's Degree in Health Economics from York University – England and an MBA in Strategy and Business Management from UFPR. He is currently the founding president of IBRAVS – Instituto Brasileiro de Valor em Saúde and KOL of several companies, being a guest speaker in Brazil and abroad, giving more than 100 lectures and classes on Value-based remuneration and health models in the last 2 years. He is the author of the P4P© model (2008) which evolved in 2011 to the GPS.2iM© model, which aims to evaluate the performance of health professionals and services. This model is currently part of more than a hundred programs in Hospitals, Health Plans and SUS in Brazil. In 2019, it developed the Health Value Score (HVS) at 2iM, a unique measure that has practical application in Value Based Health projects and remuneration models. He was an ANS consultant for QUALISS in a project commissioned by PAHO, where his model served as a theoretical reference. In 2015 he published the book “Payment for Performance, the Challenge of Evaluating Health Performance in Brazil” (DOC Content Publisher), in addition to several articles on this topic, being a columnist in Saúde Business Web. He has over 30 years' experience in the areas of management, auditing, consulting and entrepreneurship in the health area. He founded several health companies and was Superintendent Director of the Health Assistance Department of the Government of the State of Paraná between 2002 and 2005 with the responsibility of managing the health plan with more than 500 thousand lives in the State of Paraná. For a long time he was founding president of SOMAP – Society of Medical Auditors of the State of Paraná and founded and chaired CONIASP – National Council of Health Care Institutions for Public Servants, which currently became CONESSP – Council of Health Entities of Public Servants.DR. CÉSAR ABICALAFFE

JOSIANE JUSTUS
Partner and Market and Relationship Manager
Nurse, Master in Health Information Technology, PUC-PR, Postgraduate in Administration in Health Plans by PUC-PR, Specialist in Nursing Auditing, by the Brazilian Society of Nurses Auditors, was President of the Society of Nurses Auditors-PR. She worked in a hospital environment for more than 8 years and as a Health Plans Operator for more than 5 years. Certified by Lifecare INC – USA, in Homecare and by Biomedical System – USA, in Case Management Programs. Postgraduate Professor in the Auditing and Management courses at UTP, Uningá and in Administration in Nursing Services at PUC-PR. Instructor of training courses and capacity building of teams in health costs throughout Brazil. She was Managing Partner of Impacto Health Technology Management from 1995 to 2017 and since 2011 Member of 2iM Inteligência Médica.JOSIANE JUSTUS

SOLANGE ABICALAFFE SERCI
Partner and Administrative Financial Manager
Graduated from the FAE Business School in Business Administration, post-graduated from the Tuiuti University in Auditing and Health Management and Postgraduate in Controllership. She started as Administrator and representative of Helicom Film, in the training areas, as Manager at III Milênio School and as Administrative Manager at Graal Medical Clinic, Delta Saúde, occupational health company. She worked for 18 years as Administrative Manager at Impacto Health Audit S/A. She is currently Administrative Manager at 2iM Impacto Inteligência Médica S/A.SOLANGE ABICALAFFE SERCI
Associated Consultants

DR. ANDRÉ MÉDICI
Senior Health Economist|World Bank
He is an administrator at FGV, with a master's degree in economics from UNICAMP and a doctorate in economic history from USP, in addition to specialization courses in social security at Harvard University. He has dedicated himself for more than thirty years, to issues of economics and health management and other social policies (work, social assistance, population policies, demography, social security, education, sanitation and the environment). He held positions in public administration and in the Brazilian academy, as well as a consultant to the private health sector in the country. He participated in the movement for the construction of SUS in Brazil, having been, in 1986, coordinator of the Technical Group on Health Financing of the National Health Reform Commission (CNRS). He was the second president of the Brazilian Health Economics Association (ABRES). He was Coordinator of the Social Policies Area at the Public Sector Economics Institute (IESP) and Deputy Director of Population at IBGE (Brazilian Institute of Geography and Statistics). He worked as a consultant in several international organizations and, since 1996, he moved to Washington to occupy positions in multilateral organizations (Inter-American Development Bank, where he retired, and the World Bank), where he has participated in several international projects and initiatives on topics such as health accreditation, patient safety, health economics, health reform, strategic planning and health priorities. He was part of International Health Committees, led and participated in the preparation and discussion of health projects in Brazil and in several countries in Latin America, Southeast Asia, South Asia and other continents. He has more than 10 books and 200 papers published in different languages and fields of knowledge, but with a focus on health economics and health policies, health management. He has also published on other social policies, including the environmental area. Among his published books are: (a) Options for Tobacco Taxation in Afghanistan, Ed. World Bank, 2019; (b) Economic Dimensions of NCDs in Latin America (Ed. DCP3&PAHO/WHO, 2016) (c) From Global to Local: Health Challenges at the Edge of the 21st Century [Do Global ao Local: Os Desafios da Saúde no Limiar do Século XXI] (Ed. COOPMED, 2011); (d) The Knight of Health (co-authored with Silvia Czapsiki, about the life of Julian Czapski, 2011, Ed. Novo Século); (e) The Decentralization Challenge [O Desafio da Descentralização] (in Spanish and Portuguese, Ed. IDB, 2002); (f) The Political Economy of Health Reforms [Economia Política das Reformas de Saúde] (Ed. IAHCS, 1996); and (g) Economy and Health in Brazil: Balance and Perspectives of the Decentralization Process [Economia e Saúde no Brasil: Balanços e Perspectivas do Processo de Descentralização] (Ed.USP, 1995). He is editor of the Blog Monitor de Saúde.DR. ANDRÉ MÉDICI

DR. ANDRÉ OSMO
New Business Superintendent | Hospital Sírio-Libanês
He held management positions at Hospital das Clínicas, Faculty of Medicine, University of São Paulo, Albert Einstein Israeli Hospital and Sírio-Libanês Hospital. He is currently a member of the team of expert consultants of the Strategy and Projects Directorate of Sírio Libanês Hospital and coordinated the team to implement the APR-DRG system at the institution. Operates in projects of New Health Remuneration Models and in the development of analysis tools for APR-DRG in Brazil.DR. ANDRÉ OSMO

DR. WALTER LYRIO DO VALLE
Medical Management
Physician graduated from the Federal University of São Paulo (UNIFESP), specializing in General Surgery, Public Health and Hospital Management and an MBA in Health Management from Hospital das Clínicas in São Paulo. He was Technical Director at Unidas, Deputy Director of Medial's accredited network management, Medical Manager at VIVO and CESP Foundation. He currently coordinates the audit of SUS, is an Advisor to the Executive Board of the Hospital das Clínicas of the University of São Paulo (USP) and Medical Auditor and accredited network manager of the State of São Paulo Tax Authorities. He acts as a consultant and advisor to the Brazilian Federation of Hospitals (FBH) and the Association of Hospitals of the State of São Paulo (AHESP). He is a member of the technical groups of the National Supplementary Health Agency (ANS), the Health Information Standardization Committee (COPISS) and New Hospital Compensation Models. At 2iM, he works as a senior consultant, specializing in the product GPS-HOSPITALS to assess the performance of the clinical staff and inpatient units.DR. WALTER LYRIO DO VALLE

DR. MARCELO CUNIO MACHADO FONSECA, MD, PHD
Health Economics
Pediatric physician graduated from the Federal University of São Paulo (UNIFESP), specialized in pediatric Intensive Care, master in Economics and Health Management and PhD in medicine by the same institution. He completed the Marketing and Management extension courses at the American Management Association and Clinical Epidemiology and Biostatistics at Harvard School of Public Health. He is an undergraduate and graduate professor at the Faculty of Health Technologies at UNIFESP, where he teaches Health Technology Assessment, Clinical Research and Pediatrics. Still at UNIFESP, he was the founder of the Clinical Trials Center and is currently the general manager of the Health Technology Assessment Center (NATS). He is president of the Brazilian Chapter of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).DR. MARCELO CUNIO MACHADO FONSECA, MD, PhD

GABRIELA TANNUS BRANCO DE ARAÚJO, MSc
Health Economics
Economist graduated from Armando Álvares Penteado Foundation (FAAP), with an extension course in Marketing at School of Higher Education in Advertising and Marketing (ESPM) and an MBA in Economics and Health Management from UNIFESP. Master in Health Sciences from UNIFESP and PhD student at the same institution. She also took the on-site extension courses Leading Professional Services Firms and Business Innovations in Global Health Care Delivery at Harvard Business School. Specialist in charge of the Office of Health Technology Assessments at UNIFESP. She is currently vice president of the Brazilian Chapter of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and member of the Executive Committee of the Latin American Consortium of ISPOR.GABRIELA TANNUS BRANCO DE ARAÚJO, MSc

JOÃO MARQUES GOMES
Chairman, Nova Institute for Value Improvement in Health and Care
He is a professor of Health Management at Nova School of Business & Economics and Nova Medical School. He is the Chair of the Nova Institute for Value Improvement in Health and Care and CEO of Nova SBE Health Economics & Management. As a management consultant, João Marques Gomes worked for public and private hospitals in Europe and Latin America, European Commission, Portuguese Ministry of Health, Order of Pharmacists, and for pharmaceutical companies that are among the 10 largest companies worldwide in sales. He holds a doctorate in economics and an MBA.JOÃO MARQUES GOMES

ANDRÉ GUSTAVO DAHER VIANNA
President of the Brazilian Diabetes Society
Doctor graduated from UFPR in 1999. He did medical residency in Clinical Medicine at HC-UFPR and in Endocrinology and Metabology at Brigadeiro Hospital, SP between 2000-2004. He completed a doctorate in Health Sciences at PUC-PR in 2017. He is currently President of Brazilian Diabetes Society (SBD), Regional Paraná, in the 2020-21 biennium and is also part of the New Technologies department of SBD Nacional. He works as a doctor, researcher and Executive Director of the Diabetes Center Curitiba, located at Hospital Nossa Senhora das Graças. He was a professor at the Faculty of Medicine at PUC-PR between 2012-2015 and since 2015 has served as a preceptor of the specialization in endocrinology and metabolism at Nossa Senhora das Graças Hospital. He is also a founding partner of Intelmed – Medical Intelligence (Medical Intelligence), a company specialized in consulting and development of solutions in the health area. In addition to working actively in the care and assistance of endocrinological patients, he has been a consultant physician for the pharmaceutical and health market since 2010, as well as giving lectures in the area of endocrinology and diabetes since 2009.ANDRÉ GUSTAVO DAHER VIANNA

DR. MARCELO CUNIO MACHADO FONSECA, MD, PhDEconomia em Saúde
Médico pediatra formado pela Universidade Federal de São Paulo (UNIFESP), especializado em Terapia Intensiva pediátrica, mestre em Economia e Gestão da Saúde e PhD em medicina pela mesma instituição. Concluiu os cursos de extensão Marketing and Management pela American Management Association e Clinical Epidemiology and Biostatistics pela Harvard School of Public Health. É professor de graduação e pós-graduação na Faculdade de Tecnologias em Saúde da UNIFESP, onde ministra Avaliação de Tecnologia da Saúde, Pesquisa Clínica e Pediatria. Ainda na UNIFESP, foi o fundador do Núcleo de Ensaios Clínicos e é atualmente o gerente geral do Núcleo de Avaliação de Tecnologias em Saúde (NATS). É presidente do Capítulo Brasileiro da International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

ANDRÉ GUSTAVO DAHER VIANNAPresidente da Sociedade Brasileira de Diabetes
Médico graduado pela UFPR em 1999. Fez residência médica em Clínica Médica pelo HC-UFPR e em Endocrinologia e Metabologia pelo Hospital Brigadeiro - SP entre 2000-2004. Concluiu doutorado em Ciências da Saúde pela PUC-PR em 2017. Atualmente é Presidente da Sociedade Brasileira de Diabetes (SBD), Regional Paraná, no biênio 2020-21 e também faz parte do departamento de Novas Tecnologias da SBD Nacional. Atua como médico, pesquisador e Diretor Executivo do Centro de Diabetes Curitiba, localizado no Hospital Nossa Senhora das Graças. Foi professor da faculdade de Medicina da PUC-PR entre 2012-2015 e desde 2015 atua como preceptor da especialização em endocrinologia e metabologia do Hospital Nossa Senhora das Graças. É também sócio fundador da Intelmed – Inteligência Médica, empresa especializada em consultoria e desenvolvimento de soluções na área de saúde. Além de trabalhar ativamente no atendimento e assistência a pacientes endocrinológicos, atua como médico consultor para o mercado farmacêutico e de saúde desde 2010, assim como profere palestras na área de endocrinologia e diabetes desde 2009.
Partners



Gold trading partner.

Medical specialists for the development of DM.Analytics.
AKRIVOS
Medical specialists and relationship with the academy for MOM.

Medical specialists and consultants for some lines of care.

Value analysis model of associated hospitals and benchmarking.

Qualification of associates and benchmarking.

Partner institution in discussions on Value-Based Health.

Plataforma de referenciamento de mercado, que busca contribuir para a criação de um Sistema de Valor Sustentável e a evolução do Setor de Saúde.
Code of conduct
The essence of 2iM®’s business is the aggregation and integration of data from different players in the health field, whether public or private. Thus, the result of our work is the knowledge of sensitive data. In this sense, the 2iM® Code of Conduct establishes our line of conduct and the way we deal with this fact.
It aims to reinforce our values and principles, specifying our work conduct, especially with regard to the relationship with patients, clients and outsourced consultants, whether in the public or private area.
Following the main ethical, anti-corruption and transparency standards is our role and responsibility. Thus, we contribute to the good corporate governance of our company and our clients and partners by managing the risks relevant to our activity.
With patients
We guarantee the confidentiality and secrecy of the personal data required by the Brazilian Constitution of 1988 in its fifth article.
For the dissemination of results, we work with absolute data, preferably numerical and in acronyms so as not to individualize and detail personal statements.
We do not disclose the patient's name, at most his initials and location. To avoid homonyms, or even research bias due to the fact that the patient changes doctors, we use the initials of the mother's name.
We do not use sensitive information, such as the disease or signs and symptoms that the patient has, for his own purposes, to help any interested party or harm any other party.
We recognize and respect that the patient is the only one entitled to disclose his confidential information or authorize (in writing) his disclosure.
We do not work or take gifts or any item, of any value, that may appear to be a favor exchange.
With doctors and other health service providers
The data of doctors and other health service providers are not identified, at most including initials, city of service, region and specialty or type of provider.
We recognize and respect that the physician is the guardian of patient information.
We do not interfere with the treatment conduct established by the doctor.
With the pharmaceutical industry
We do not provide specific data or information from patients, doctors or other healthcare providers.
In communication materials, our or clients', we respect the established by the norms in force in the country (RDC 96).
We guarantee the secrecy and confidentiality of the strategic information obtained. We are custodians of any and all material delivered, original or copy, that contains confidential strategic information. At the end, we return, along with the work done, all the material delivered.
With clients, public or private managers and strategic alliances
We do not practice or encourage bribery and corruption.
We do not take messages to third parties, whatever it may be.
We do not provide specific patient or physician data or information.
We seek to establish contracts, terms of responsibility and confidentiality in the work performed.
“Confidential information” means information of confidential nature or property originated from one of the parties and disclosed to the other, comprising issues of technical nature, such as business secrets, methods, prototypes, data, ideas, designs, formulation, know-how, and similar items that can be disclosed and are not classified as public information or published in business sources, in addition to any piece of information classified as confidential by the client and 2iM®".
2iM®’s employees, partners, and collaborators in general have access to several pieces of information of 2iM®’s clients: doctors, patients, among others. All this information shall be deemed as “confidential information” all the time and for every purpose, and its disclosure is unauthorized.
We work with public information and identify the research sources to demonstrate and specify the origin thereof.
We ensure and keep confidentiality for three years after the work’s submission and we do not employ these data for other works, respecting the free competition.
We do not employ confidential information for personal gain.
We do not copy, transcribe, or transmit confidential information without prior written consent of the related parties.
We do not employ or hire, even for temporary consultancy, professionals submitted to public service relations or employed by the government, state companies or those controlled by public agencies or bodies (including governmental medical or health institutions or those managed by the government), whose position would allow the undue influence or promotion of any party’s interest, especially regarding bids and public purchases.
We do not employ or hire individuals under 18 years old or encourage practices that lead to child labor.
We respect the intellectual properties of the authors and creators.
On demand, we provide copies of the tax collections (INSS, ISS, PIS, Income Tax, FGTS, Union Contribution, among others) and other documents that are deemed necessary.
We return every material submitted to us for the accomplishment of the work.
We work accordingly and follow the regulations acknowledged as the standard of ethics, transparency, and respect:
• “FCPA - Foreign Corruption Practices Act” (ANTI-BRIBERY PROVISION) Legislation of the United States of America that is applicable to companies with headquarters therein and branches in other countries;
• Law 10467/2002, Law 9613/1998, article 333 of Law 2848/40 (Penal Code), Behavioral Code of the High Federal Administration and By-laws of the Civil Public Servant;
• Law no 3,268, of September 30, 1957, regulated by ordinance no 44,045, of July 19, 1958, added by Law no 11,000, of December 15, 2004, and ordinance no 6,821, of April 14, 2009;
• Art. 2 and Art. 15 of Law no 3,268/57;
• Art. 16 of the ordinance-Law no 20,931/32, letters c, g, and h;
• Code of Medical Ethics - Resolution CFM No 1,931/09;
• Policy of the National Card of Health CNS and confidentiality on the patient’s data.
Our Clients
































